Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss

Multiple myeloma (MM) is a plasma cell malignancy, characterized by osteolytic lesions and monoclonal immunoglobulins. The anemia, accompanying the disease is often treated with recombinant human EPO. Diverse non-erythropoietic effects of EPO have led us to question its combined action on the immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Deshet-Unger, Naamit, Hiram-Bab, Sahar, Haim-Ohana, Yasmin, Mittelman, Moshe, Gabet, Yankel, Neumann, Drorit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969594/
https://www.ncbi.nlm.nih.gov/pubmed/27481313
http://dx.doi.org/10.1038/srep30998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969594/
https://www.ncbi.nlm.nih.gov/pubmed/27481313
http://dx.doi.org/10.1038/srep30998

Ejemplares similares